CARD9 deficiency promotes pancreatic cancer growth by blocking dendritic cell maturation via SLC6A8-mediated creatine transport

References

• Da Y, Liu Y, Hu Y, Liu W, Ma J, Lu N, Zhang C, Zhang C. STING agonist cGAMP enhances anti-tumor activity of CAR-NK cells against pancreatic cancer. OncoImmunology. 2022;21(1):2054105. doi:10.1080/2162402X.2022.2054105.
   Google Scholar
• Li X, Gulati M, Larson AC, Solheim JC, Jain M, Kumar S, Batra SK. Immune checkpoint blockade in pancreatic cancer: trudging through the immune desert. Semin Cancer Biol. 2022;86:14–15. doi:10.1016/j.semcancer.2022.08.009.
   PubMed Web of Science ®Google Scholar
• O’Donnell JS, Teng MWL, Smyth MJ. Cancer immunoediting and resistance to T cell-based immunotherapy. Nat Rev Clin Oncol. 2019;16(3):151–167. doi:10.1038/s41571-018-0142-8.
   PubMed Web of Science ®Google Scholar
• Lau SP, van Montfoort N, Kinderman P, Lukkes M, Klaase L, van Nimwegen M, van Gulijk M, Dumas J, Mustafa DAM, Lievense SLA, et al. Dendritic cell vaccination and CD40-agonist combination therapy licenses T cell-dependent antitumor immunity in a pancreatic carcinoma murine model. J ImmunoTher Cancer. 2020;8(2):e000772. doi:10.1136/jitc-2020-000772.
   PubMed Web of Science ®Google Scholar
• Yang J, Shangguan J, Eresen A, Li Y, Wang J, Zhang Z. Dendritic cells in pancreatic cancer immunotherapy: vaccines and combination immunotherapies. Pathol Res Pract. 2019;215(12):152691. doi:10.1016/j.prp.2019.152691.
   PubMed Web of Science ®Google Scholar
• Lin JH, Huffman AP, Wattenberg MM, Walter DM, Carpenter EL, Feldser DM, Beatty GL, Furth EE, Vonderheide RH. Type 1 conventional dendritic cells are systemically dysregulated early in pancreatic carcinogenesis. J Exp Med. 2020;217(8):e20200816. doi:10.1084/jem.20190673.
   PubMed Web of Science ®Google Scholar
• Hegde S, Krisnawan VE, Herzog BH, Zuo C, Breden MA, Knolhoff BL, Hogg GD, Tang JP, Baer JM, Mpoy C, et al. Dendritic cell paucity leads to dysfunctional immune surveillance in pancreatic cancer. Cancer Cell. 2020;37(3):289–307. doi:10.1016/j.ccell.2020.02.008.
   PubMed Web of Science ®Google Scholar
• Shangguan A, Shang N, Figini M, Pan L, Yang J, Ma Q, Hu S, Eresen A, Sun C, Wang B, et al. Prophylactic dendritic cell vaccination controls pancreatic cancer growth in a mouse model. Cytotherapy. 2020;2(1):6–15. doi:10.1016/j.jcyt.2019.12.001.
   Google Scholar
• Lau SP, Klaase L, Vink M, Dumas J, Bezemer K, van Krimpen A, van der Breggen R, Wismans LV, Doukas M, de Koning W, et al. Autologous dendritic cells pulsed with allogeneic tumour cell lysate induce tumour-reactive T-cell responses in patients with pancreatic cancer: a phase I study. Eur J Cancer. 2022;169:20–31. doi:10.1016/j.ejca.2022.03.015.
   PubMed Web of Science ®Google Scholar
• Giovanelli P, Sandoval TA, Cubillos-Ruiz JR. Dendritic cell metabolism and function in tumors. Trends Immunol. 2019;40(8):699–718. doi:10.1016/j.it.2019.06.004.
   PubMed Web of Science ®Google Scholar
• Peng X, He Y, Huang J, Tao Y, Liu S. Metabolism of dendritic cells in tumor microenvironment: for immunotherapy. Front Immunol. 2021;12:613492. doi:10.3389/fimmu.2021.613492.
   PubMed Web of Science ®Google Scholar
• Ray A, Song Y, Du T, Tai Y-T, Chauhan D, Anderson KC. Targeting tryptophan catabolic kynurenine pathway enhances antitumor immunity and cytotoxicity in multiple myeloma. Leukemia. 2020;34(2):567–577. doi:10.1038/s41375-019-0558-x.
   PubMed Web of Science ®Google Scholar
• Liu X, Jiang B, Hao H, Liu Z. CARD9 signaling, inflammation, and diseases. Front Immunol. 2022;13:880879. doi:10.3389/fimmu.2022.880879.
   PubMed Web of Science ®Google Scholar
• Jeantin L, Plu I, Amador MDM, Maillart E, Lanternier F, Pourcher V, Davy V. Pearls & Oy-sters: spinal cord candidiasis linked to CARD9 deficiency masquerading as a longitudinally extensive transverse myelitis. Neurology. 2022;99(11):475–479. doi:10.1212/WNL.0000000000200992.
   PubMed Web of Science ®Google Scholar
• Zhong X, Chen B, Yang L, Yang Z. Card9 as a critical regulator of tumor development. Cancer Lett. 2019;451:150–155. doi:10.1016/j.canlet.2019.03.001.
   PubMed Web of Science ®Google Scholar
• Zhang H, Wang Y, Men H, Zhou W, Zhou S, Liu Q, Cai L. CARD9 regulation and its role in cardiovascular diseases. Int J Biol Sci. 2022;18(3):970–982. doi:10.7150/ijbs.65979.
   PubMed Web of Science ®Google Scholar
• Tian C, Tuo YL, Lu Y, Xu C-R, Xiang M. The role of CARD9 in metabolic diseases. Curr Med Sci. 2020;40(2):199–205. doi:10.1007/s11596-020-2166-4.
   PubMed Web of Science ®Google Scholar
• Qu J, Liu L, Xu Q, Ren J, Xu Z, Dou H, Shen S, Hou Y, Mou Y, Wang T. CARD9 prevents lung cancer development by suppressing the expansion of myeloid-derived suppressor cells and IDO production. Int J Cancer. 2019;145(8):2225–2237. doi:10.1002/ijc.32355.
   PubMed Web of Science ®Google Scholar
• Malik A, Sharma D, Malireddi RKS, Guy CS, Chang T-C, Olsen SR, Neale G, Vogel P, Kanneganti T-D. SYK-CARD9 signaling axis promotes gut fungi-mediated inflammasome activation to restrict colitis and colon cancer. Immunity. 2018;49(3):515–530. doi:10.1016/j.immuni.2018.08.024.
   PubMed Web of Science ®Google Scholar
• Loo JM, Scherl A, Nguyen A, Man F, Weinberg E, Zeng Z, Saltz L, Paty P, Tavazoie S. Extracellular metabolic energetics can promote cancer progression. Cell. 2015;160(3):393–406. doi:10.1016/j.cell.2014.12.018.
   PubMed Web of Science ®Google Scholar
• Di Biase S, Ma X, Wang X, Yu J, Wang Y-C, Smith DJ, Zhou Y, Li Z, Kim YJ, Clarke N, et al. Creatine uptake regulates CD8 T cell antitumor immunity. J Exp Med. 2019;216(12):2869–2882. doi:10.1084/jem.20182044.
   PubMed Web of Science ®Google Scholar
• Ji L, Zhao X, Zhang B, Kang L, Song W, Zhao B, Xie W, Chen L, Hu X. Slc6a8-mediated creatine uptake and accumulation reprogram macrophage polarization via regulating cytokine responses. Immunity. 2019;51(2):272–284. doi:10.1016/j.immuni.2019.06.007.
   PubMed Web of Science ®Google Scholar
• Zhang L, Bu P. The two sides of creatine in cancer. Trends Cell Biol. 2022;32(5):380–390. doi:10.1016/j.tcb.2021.11.004.
   PubMed Web of Science ®Google Scholar
• Elgebaly SA, Todd R, Kreutzer DL, Christenson R, El-Khazragy N, Arafa RK, Rabie MA, Mohamed AF, Ahmed LA, El Sayed NS. Nourin-associated miRnas: novel inflammatory monitoring markers for cyclocreatine phosphate therapy in heart failure. Int J Mol Sci. 2021;22(7):3575. doi:10.3390/ijms22073575.
   PubMed Web of Science ®Google Scholar
• Munisvaradass R, Kumar S, Govindasamy C, Alnumair K, Mok P. Human CD3+ T-Cells with the Anti-ERBB2 chimeric antigen receptor exhibit efficient targeting and induce apoptosis in erbb2 overexpressing breast cancer cells. Int J Mol Sci. 2017;18(9):1797. doi:10.3390/ijms18091797.
   PubMed Web of Science ®Google Scholar
• Yan L, Tan Y, Chen G, Fan J, Zhang J. Harnessing metabolic reprogramming to improve cancer immunotherapy. Int J Mol Sci. 2021;22(19):10268. doi:10.3390/ijms221910268.
   PubMed Web of Science ®Google Scholar
• Li DD, Jawale CV, Zhou C, Lin L, Trevejo-Nunez GJ, Rahman SA, Mullet SJ, Das J, Wendell SG, Delgoffe GM, et al. Fungal sensing enhances neutrophil metabolic fitness by regulating antifungal Glut1 activity. Cell Host & Microbe. 2022;30(4):530–544. doi:10.1016/j.chom.2022.02.017.
   PubMed Web of Science ®Google Scholar
• Plesca I, Benesova I, Beer C, Sommer U, Müller L, Wehner R, Heiduk M, Aust D, Baretton G, Bachmann MP, et al. Clinical significance of tumor-infiltrating conventional and plasmacytoid dendritic cells in pancreatic ductal adenocarcinoma. Cancers. 2022;14(5):1216. doi:10.3390/cancers14051216.
   PubMed Web of Science ®Google Scholar
• Meyer MA, Baer JM, Knolhoff BL, Nywening TM, Panni RZ, Su X, Weilbaecher KN, Hawkins WG, Ma C, Fields RC, et al. Breast and pancreatic cancer interrupt IRF8-dependent dendritic cell development to overcome immune surveillance. Nat Commun. 2018;9(1):1250. doi:10.1038/s41467-018-03600-6.
   PubMed Web of Science ®Google Scholar
• Li J, Ding H, Meng Y, Li G, Fu Q, Guo Q, Yin Z, Ye Z, Zhou H, Shen N. Taurine metabolism aggravates the progression of lupus by promoting the function of plasmacytoid dendritic cells. Arthritis Rheumatol. 2020;72(12):2106–2117. doi:10.1002/art.41419.
   PubMed Web of Science ®Google Scholar
• Ulland TK, Song WM, Huang SC, Ulrich JD, Sergushichev A, Beatty WL, Loboda AA, Zhou Y, Cairns NJ, Kambal A, et al. TREM2 maintains microglial metabolic fitness in alzheimer’s disease. Cell. 2017;170(4):649–663. doi:10.1016/j.cell.2017.07.023.
   PubMed Web of Science ®Google Scholar
• Zhao H, Wu L, Yan G, Chen Y, Zhou M, Wu Y, Li Y. Inflammation and tumor progression: signaling pathways and targeted intervention. Signal Transduct Target Ther. 2021 Jul 12;6(1):263. doi:10.1038/s41392-021-00658-5.
   PubMed Web of Science ®Google Scholar
• Zeidi M, Kim HJ, Werth VP. Increased myeloid dendritic cells and TNF-α expression predicts poor response to hydroxychloroquine in cutaneous lupus erythematosus. J Invest Dermatol. 2019;139(2):324–332. doi:10.1016/j.jid.2018.07.041.
   PubMed Web of Science ®Google Scholar